Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sable Bio
London, England, United Kingdomsablebio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Sable Bio has developed an AI-driven platform that aggregates and analyzes clinical, genetic, experimental, and literature data to provide predictive toxicology insights. The technology enables faster, systematic risk assessment of drug targets—helping scientists prioritize safer candidates and reduce the risk of clinical trial failures due to unforeseen toxicity. The company recently raised a €1.7 million pre-seed round led by Episode 1 Ventures and Seedcamp[2]. No direct clinical results as it is not a therapeutic developer.
- Therapeutic areas
- Other
- Modalities
- Not directly developing therapeutics; focuses on drug safety data and toxicology insights for all modalities[1][2][3].
- Industry
- Drug Discovery Services
02
Partnerships
Currently seeking partnerships with biotech, pharma, healthtech companies, as well as academic collaborations[2].
Beyond the preview
Go deeper on Sable Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sable Bio.